Search research articles
Contact Us
Filters
Showing results (401-410 of 489) with videos related to
Page
of 49
Sort By:
Science Translational Medicine
|
June 14, 2023
Gut microbiome composition may be an indicator of preclinical Alzheimer's disease
Aura L Ferreiro, JooHee Choi, Jian Ryou, et al.
Nature Medicine
|
January 16, 2019
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction
Daniel A Nation, Melanie D Sweeney, Axel Montagne, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 14, 2023
Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's disease
Chengjie Xiong, Lena M McCue, Virginia Buckles, et al.
Neurology
|
April 22, 2022
Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light
Suzanne E Schindler, Thomas K Karikari, Nicholas J Ashton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 12, 2020
Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning
Nicolai Franzmeier, Nikolaos Koutsouleris, Tammie Benzinger, et al.
Science Translational Medicine
|
March 7, 2014
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease
Anne M Fagan, Chengjie Xiong, Mateusz S Jasielec, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
April 25, 2017
Preclinical Alzheimer's disease and longitudinal driving decline
Catherine M Roe, Ganesh M Babulal, Denise M Head, et al.
Brain : a Journal of Neurology
|
December 17, 2021
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
Allan I Levey, Deqiang Qiu, Liping Zhao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 26, 2011
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, et al.
JAMA Neurology
|
January 13, 2015
Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study
Adam S Fleisher, Kewei Chen, Yakeel T Quiroz, et al.
Page
of 49
Search research articles
Search
Showing results (401-410 of 489) with videos related to
Sort By:
Page
of 49
Science Translational Medicine
|
June 14, 2023
Gut microbiome composition may be an indicator of preclinical Alzheimer's disease
Aura L Ferreiro, JooHee Choi, Jian Ryou, et al.
Nature Medicine
|
January 16, 2019
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction
Daniel A Nation, Melanie D Sweeney, Axel Montagne, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 14, 2023
Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's disease
Chengjie Xiong, Lena M McCue, Virginia Buckles, et al.
Neurology
|
April 22, 2022
Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light
Suzanne E Schindler, Thomas K Karikari, Nicholas J Ashton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 12, 2020
Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning
Nicolai Franzmeier, Nikolaos Koutsouleris, Tammie Benzinger, et al.
Science Translational Medicine
|
March 7, 2014
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease
Anne M Fagan, Chengjie Xiong, Mateusz S Jasielec, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
April 25, 2017
Preclinical Alzheimer's disease and longitudinal driving decline
Catherine M Roe, Ganesh M Babulal, Denise M Head, et al.
Brain : a Journal of Neurology
|
December 17, 2021
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
Allan I Levey, Deqiang Qiu, Liping Zhao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 26, 2011
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, et al.
JAMA Neurology
|
January 13, 2015
Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study
Adam S Fleisher, Kewei Chen, Yakeel T Quiroz, et al.
Page
of 49